Oncology Pharma Inc.

Oncology Pharma Inc.

ONPH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.33M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oncology Pharma Inc.Oncology Pharma Inc.-508.2--509%-0.7
$-0.02

Current Fair Value

153.1% downside

Overvalued by 153.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.33 Million
Enterprise Value$4.10 Million
Earnings per Share$0
Beta-0.13
Outstanding Shares82,164,642

Return

Return on Equity-508.83%ROE
Return on Assets-261.74%
Return on Invested Capital-24.95%

Valuation & Multiples

P/E Ratio-508.23P/E Ratio
PEG509.88PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-14.95
Enterprise Value to Net Income-1
Total Debt to Enterprise0.19
Debt to Equity0.71Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Oncology Pharma Inc.

1 employees
CEO: George Malesek

Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeu...